Advertisement
Advertisement

EQ

EQ logo

Equillium, Inc. Common Stock

2.92
USD
Sponsored
+0.07
+2.46%
Jun 25, 09:59 UTC -4
Open

EQ Earnings Reports

Positive Surprise Ratio

EQ beat 21 of 31 last estimates.

68%

Next Report

Date of Next Report
Aug 12, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/
-$0.05
Implied change from Q1 26 (Revenue/ EPS)
--
/
-16.67%
Implied change from Q2 25 (Revenue/ EPS)
--
/
-68.75%

Equillium, Inc. Common Stock earnings per share and revenue

On May 13, 2026, EQ reported earnings of -0.06 USD per share (EPS) for Q1 26, missing the estimate of -0.04 USD, resulting in a -34.53% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +12.12% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 4 analysts forecast an EPS of -0.05 USD, with revenue projected to reach -- USD, implying an decrease of -16.67% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
enGene Therapeutics Inc. Common Stock
Report Date
Jun 15, 2026 For Q2 26
Estimate
-$0.47
Actual
-$0.43
Surprise
+10.32%
logo
Grace Therapeutics, Inc. Common Stock
Report Date
Jun 18, 2026 For Q4 26
Estimate
-$0.23
Actual
-$0.06
Surprise
+74.42%
logo
Vistagen Therapeutics, Inc. Common Stock
Report Date
Jun 15, 2026 For Q4 26
Estimate
-$0.34
Actual
-$0.37
Surprise
-7.75%
FAQ
For Q1 2026, Equillium, Inc. Common Stock reported EPS of -$0.06, missing estimates by -34.53%, and revenue of $0.00, 0% as expectations.
The stock price moved up 12.12%, changed from $2.31 before the earnings release to $2.59 the day after.
The next earning report is scheduled for Aug 12, 2026.
Based on 4 analysts, Equillium, Inc. Common Stock is expected to report EPS of -$0.05 and revenue of -- for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement